Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Outpatient overprescribing: ‘Cultural shift’ needed to spare antibiotics
• Global surveillance as an antimicrobial stewardship strategy: Updates from ASM Microbe 2018 George G. Zhanel, PhD PharmD
• Black MSM in South underrepresented in HIV testing
• Campaign encourages young people to talk to parents about HPV vaccine
• Global coverage of HBV treatment remains low despite declining costs
• Novartis exit more bad news for antibiotics research
• Report details outbreaks linked to untreated recreational water
• Researchers identify first known case of PrEP failure in developing country
• Should reviews of physicians be allowed on Yelp?
• Tribute to Ted Eickhoff: Infectious disease practitioners as public health advocates Kathleen F. Gensheimer, MD MPH FIDSA
• Fosfomycin for uncomplicated cystitis in women: Less for more? Donald Kaye, MD, MACP
• FDA approves Krintafel for P. vivax malaria prevention in teens, adults
• FDA approves TPOXX to treat smallpox
• FDA approves Zemdri to treat cUTIs, but not bloodstream infection
• FDA strengthens safety warnings for fluoroquinolones
• US will no longer test individual blood donations for Zika
• As Ebola outbreak ends in Congo, new cluster emerges
• $20 HBV test may increase treatment coverage in Africa
• Among ESBL-producing organisms, K. pneumoniae may be deadlier than E. coli
• Antibiotic prophylaxis for recurring UTIs effective; resistance a concern
• Booklet reduces antibiotic prescribing for childhood fever
• Citizen scientists discover disease-carrying ticks in 83 new US counties
• CMS policy had minimal effect on CLABSI, CAUTI trends
• Current Shingrix vaccination schedule unlikely cost-effective
• Free testing, drug discounts improve use of ACTs for malaria
• Gene study shows men may need higher antibiotic doses for gonorrhea
• Grapes pressed with infected mice caused tularemia outbreak at German winery
• HCV vaccine could reduce transmission in people who inject drugs
• High numbers of HIV-positive MSM not being tested for syphilis
• Highest resolution image of Zika virus can guide vaccine development
• IAS-USA updates recommendations for treatment, prevention of HIV
• IDSA, ASM update lab diagnosis guide
• IgA response poor indicator of rotavirus vaccine protection in infants
• ‘Less can be more’: Shorter rabies PrEP schedule safe, effective
• Less than 20% of teen girls with PID screened for HIV, syphilis
• Many high-risk patients report not being tested for HIV at clinical visit
• Many travelers misuse ‘standby’ antibiotics
• Most armadillos in Brazilian Amazon carry leprosy
• Most cholera cases spread within the home
• Most meningitis cases in UK caused by viruses
• MSM offer positive feedback on home-based PrEP care program
• Novel ‘genotype 8’ surfaces among four patients with HCV
• Online interactive program leads to lower STD rates among young MSM
• Physician preferences on antibiotic prescribing feedback may improve ASPs
• PrEP use for HIV prevention may be gateway to primary care
• Rat lungworm parasite linked to consuming raw centipedes
• ‘Remarkable’ decline of skin and soft tissue infections seen in US EDs
• Researchers create popular institution-specific antibiotic app
• Researchers identify risk factors for avian influenza at live bird markets
• Researchers use tiny transmitters to track Chagas disease-spreading ‘kissing bugs’
• Simultaneous kidney, pancreas transplant predicts SSI
• Study casts doubt on cost-effectiveness of dengue vaccine
• Study: Fidaxomicin ‘better’ option than vancomycin in many C. difficile cases
• TB vaccines ineffective against initial infection
• Tenofovir for chronic HBV reduces risk for hepatocellular carcinoma
• Transplantation of HCV-infected kidney reduces cost, improves life expectancy in HCV patients
• UTI prophylaxis increases likelihood of multidrug-resistant infection
• Village-wide antibiotic prophylaxis reduces meningitis cases in epidemic
• DRIVE-FORWARD: Doravirine sustains safety, efficacy through 96 weeks
• Measles, mumps outbreaks reveal need for hospital control strategies
• MOF vaccines could ease concerns of breaking cold chain
• Nurses ‘overlooked and underutilized’ in antimicrobial stewardship efforts
• Patients with HIV achieve virologic suppression with rapid initiation Symtuza treatment
• Patients with HIV ‘highly satisfied’ with long-acting injectable therapy
• Ibalizumab: A new treatment option for MDR HIV-1 Kati Shihadeh, PharmD, BCIDP